Literature DB >> 6386994

Incidence and cumulative frequency of endemic Lyme disease in a community.

J P Hanrahan, J L Benach, J L Coleman, E M Bosler, D L Morse, D J Cameron, R Edelman, R A Kaslow.   

Abstract

We conducted an epidemiological study of the cumulative frequency and incidence of Lyme disease in a summer community on Fire Island, New York, an area endemic for the disease. Fifteen (7.5%) of 200 persons studied in the community in 1982 reported a history of Lyme disease. An indirect immunofluorescent antibody assay showed that seventeen (9.7%) of 176 persons had serological evidence of exposure to the Lyme spirochete, including six of the 15 persons with a history of Lyme disease. Seven (0.7%-1.2%) of 600-1,000 persons in the community developed clinical symptoms and serological evidence of Lyme disease during the summer season, including two (1%) of the 200 persons in the study group. Four (3.1%) of 129 persons who had sera collected before and after the summer season demonstrated fourfold or greater rises in IgG antibody titers to the Lyme spirochete, including 2 (1.6%) persons without symptoms of Lyme disease. We conclude that the incidence of Lyme disease can be appreciably higher in endemic areas than previously recognized and that subclinical or inapparent seroconversion may occur after infection.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6386994     DOI: 10.1093/infdis/150.4.489

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  Two-year survey of the incidence of Lyme borreliosis and tick-borne encephalitis in a high-risk population in Sweden.

Authors:  R Gustafson; B Svenungsson; M Forsgren; A Gardulf; M Granström
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-10       Impact factor: 3.267

2.  Pet ownership increases human risk of encountering ticks.

Authors:  E H Jones; A F Hinckley; S A Hook; J I Meek; B Backenson; K J Kugeler; K A Feldman
Journal:  Zoonoses Public Health       Date:  2017-06-19       Impact factor: 2.702

Review 3.  Lyme disease.

Authors:  D W Rahn; S E Malawista
Journal:  West J Med       Date:  1991-06

4.  Lyme disease in New Jersey outdoor workers: a statewide survey of seroprevalence and tick exposure.

Authors:  M D Goldstein; B S Schwartz; C Friedmann; B Maccarillo; M Borbi; R Tuccillo
Journal:  Am J Public Health       Date:  1990-10       Impact factor: 9.308

5.  Longterm survey (7 years) in a population at risk for Lyme borreliosis: what happens to the seropositive individuals?

Authors:  H Fahrer; M J Sauvain; E Zhioua; C Van Hoecke; L E Gern
Journal:  Eur J Epidemiol       Date:  1998-02       Impact factor: 8.082

6.  Seroprevalence of Borrelia burgdorferi in patients with Behçet's disease.

Authors:  Fatos Onen; Dilek Tuncer; Servet Akar; Merih Birlik; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2003-04-08       Impact factor: 2.631

7.  One year follow-up study to assess the prevalence and incidence of Lyme borreliosis among Dutch forestry workers.

Authors:  H Kuiper; A P van Dam; A W Moll van Charante; N P Nauta; J Dankert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-06       Impact factor: 3.267

8.  A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato.

Authors:  Nina Wressnigg; P Noel Barrett; Eva-Maria Pöllabauer; Maria O'Rourke; Daniel Portsmouth; Michael G Schwendinger; Brian A Crowe; Ian Livey; Thomas Dvorak; Bernhard Schmitt; Markus Zeitlinger; Herwig Kollaritsch; Meral Esen; Peter G Kremsner; Tomas Jelinek; Roland Aschoff; Roland Weisser; Ingomar F K Naudts; Gerald Aichinger
Journal:  Clin Vaccine Immunol       Date:  2014-09-03

9.  Human exposure to a granulocytic Ehrlichia and other tick-borne agents in Connecticut.

Authors:  L A Magnarelli; J W Ijdo; J F Anderson; S J Padula; R A Flavell; E Fikrig
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

10.  Comparison of western blot and microimmunofluorescence as tools for Lyme disease seroepidemiology.

Authors:  J P Arzouni; M Laveran; J Beytout; O Ramousse; D Raoult
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.